Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Wu Y, Gao F, Qi J, Bi Y, Fu L, Mohan S, Chen Y, Li X, Pinto BM, Vavricka CJ, Tien P, Gao GF.

J Virol. 2016 Nov 14;90(23):10693-10700.

PMID:
27654293
3.

The global antigenic diversity of swine influenza A viruses.

Lewis NS, Russell CA, Langat P, Anderson TK, Berger K, Bielejec F, Burke DF, Dudas G, Fonville JM, Fouchier RA, Kellam P, Koel BF, Lemey P, Nguyen T, Nuansrichy B, Peiris JM, Saito T, Simon G, Skepner E, Takemae N; ESNIP3 consortium., Webby RJ, Van Reeth K, Brookes SM, Larsen L, Watson SJ, Brown IH, Vincent AL.

Elife. 2016 Apr 15;5:e12217. doi: 10.7554/eLife.12217.

4.

Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential.

Richard M, Fouchier RA.

FEMS Microbiol Rev. 2016 Jan;40(1):68-85. doi: 10.1093/femsre/fuv039. Review.

5.

Molecular evidence for interspecies transmission of H3N2pM/H3N2v influenza A viruses at an Ohio agricultural fair, July 2012.

Bowman AS, Sreevatsan S, Killian ML, Page SL, Nelson SW, Nolting JM, Cardona C, Slemons RD.

Emerg Microbes Infect. 2012 Oct;1(10):e33. doi: 10.1038/emi.2012.33.

6.

Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in Ferrets.

Gustin KM, Belser JA, Veguilla V, Zeng H, Katz JM, Tumpey TM, Maines TR.

PLoS One. 2015 May 13;10(5):e0125874. doi: 10.1371/journal.pone.0125874.

7.

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.

Keitel WA, Jackson LA, Edupuganti S, Winokur PL, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR; VTEU H3N2v Vaccine Study Work Group..

J Infect Dis. 2015 Aug 15;212(4):552-61. doi: 10.1093/infdis/jiv056.

8.

Polymerase discordance in novel swine influenza H3N2v constellations is tolerated in swine but not human respiratory epithelial cells.

Powell JD, Dlugolenski D, Nagy T, Gabbard J, Lee C, Tompkins SM, Tripp RA.

PLoS One. 2014 Oct 16;9(10):e110264. doi: 10.1371/journal.pone.0110264.

9.

Influenza A subtype H3 viruses in feral swine, United States, 2011-2012.

Feng Z, Baroch JA, Long LP, Xu Y, Cunningham FL, Pedersen K, Lutman MW, Schmit BS, Bowman AS, Deliberto TJ, Wan XF.

Emerg Infect Dis. 2014 May;20(5):843-6. doi: 10.3201/eid2005.131578.

10.

Analytical reactivity of 13 commercially available rapid influenza diagnostic tests with H3N2v and recently circulating influenza viruses.

Bose ME, Sasman A, Mei H, McCaul KC, Kramp WJ, Chen LM, Shively R, Williams TL, Beck ET, Henrickson KJ.

Influenza Other Respir Viruses. 2014 Jul;8(4):474-81. doi: 10.1111/irv.12246.

11.

Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation.

Wen F, Ma JH, Yu H, Yang FR, Huang M, Zhou YJ, Li ZJ, Tong GZ.

J Vet Sci. 2014;15(3):381-8.

12.

Phylogenetic analysis of a swine influenza A(H3N2) virus isolated in Korea in 2012.

Kim JI, Lee I, Park S, Lee S, Hwang MW, Bae JY, Heo J, Kim D, Jang SI, Kim K, Park MS.

PLoS One. 2014 Feb 11;9(2):e88782. doi: 10.1371/journal.pone.0088782.

13.

Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.

Loving CL, Lager KM, Vincent AL, Brockmeier SL, Gauger PC, Anderson TK, Kitikoon P, Perez DR, Kehrli ME Jr.

J Virol. 2013 Sep;87(17):9895-903. doi: 10.1128/JVI.01038-13.

14.

Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012.

Biggerstaff M, Reed C, Epperson S, Jhung MA, Gambhir M, Bresee JS, Jernigan DB, Swerdlow DL, Finelli L.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S12-5. doi: 10.1093/cid/cit273.

15.

Replication and immunogenicity of swine, equine, and avian h3 subtype influenza viruses in mice and ferrets.

Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Jin H, Subbarao K.

J Virol. 2013 Jun;87(12):6901-10. doi: 10.1128/JVI.03520-12.

16.

Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding.

Wu Y, Qin G, Gao F, Liu Y, Vavricka CJ, Qi J, Jiang H, Yu K, Gao GF.

Sci Rep. 2013;3:1551. doi: 10.1038/srep01551.

17.

Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus.

Cauchemez S, Epperson S, Biggerstaff M, Swerdlow D, Finelli L, Ferguson NM.

PLoS Med. 2013;10(3):e1001399. doi: 10.1371/journal.pmed.1001399.

18.

H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.

Skowronski DM, Moser FS, Janjua NZ, Davoudi B, English KM, Purych D, Petric M, Pourbohloul B.

PLoS One. 2013;8(1):e54015. doi: 10.1371/journal.pone.0054015.

19.

Reliability of a newly-developed immunochromatography diagnostic kit for pandemic influenza A/H1N1pdm virus: implications for drug administration.

Sasaki T, Kubota-Koketsu R, Takei M, Hagihara T, Iwamoto S, Murao T, Sawami K, Fukae D, Nakamura M, Nagata E, Kawakami A, Mitsubayashi Y, Ohno M, Uehara Y, Fukukawa T, Kanai Y, Kosaka M, Ikuta K.

PLoS One. 2012;7(11):e50670. doi: 10.1371/journal.pone.0050670.

20.

A comprehensive analysis of reassortment in influenza A virus.

de Silva UC, Tanaka H, Nakamura S, Goto N, Yasunaga T.

Biol Open. 2012 Apr 15;1(4):385-90. doi: 10.1242/bio.2012281.

Items per page

Supplemental Content

Support Center